跳至主要内容
临床试验/NCT05606302
NCT05606302Unknown不适用

A Multi-center Clinical Study of Drug Antibody and Precision Transfusion in China

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 14,000 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
14,000
试验地点
1
主要终点
To compare the positive rate of drug antibody between different drugs.

研究概览

简要总结

Blood samples for hemolytic anemia in patients treated with one or more of the antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin were screened for the production of drug antibodies.

详细描述

The widespread use of antibiotics and anti-tumor drugs in clinical practice leads to poor efficacy or even toxic side effects and other adverse events, which are often related to the immune response caused by the cells adsorption or binding because of the long-term use of drugs to cause the generation of antibodies or drug decomposition.The immune hemolytic anemia caused by antibiotics is more common.In this study, the remaining blood samples of patients who developed hemolytic anemia using one or more antibiotics including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium and vancomycin were preliminarily screened to determine which drugs caused hemolytic anemia.The types of diseases and antibiotics used in patients with drug-induced hemolytic anemia were also analyzed.The positive rate of drug antibody production was calculated and the difference of drug antibody production mechanism was analyzed.The blood samples of the positive patients and some negative patients were collected and preserved to prepare for the follow-up study.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Voluntary signing of informed consent;
  • No limitation on age or sex;No limitation on nationality;Regional unlimited;
  • Participates treated with one or more of the drugs including piperacillin, amoxicillin, cefazolin, cefuroxime, ceftriaxone, cefoxitin sodium, and vancomycin.

排除标准

  • High fat blood sample;
  • Sample of severe hemolysis;
  • Jaundice sample;
  • The sample is cloudy and may be contaminated with bacteria;
  • The source of the sample is unknown and cannot be traced;
  • Patients with a history of medication who were deemed inappropriate to participate in this study were evaluated by the researchers.

结局指标

主要结局

To compare the positive rate of drug antibody between different drugs.

时间窗: through study completion, an average of 3 years.

The drug-induced hemolytic anemia test kit (microcolumn gel method) was used to determine whether drug antibodies were produced in the participates.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验